Carl Nathan

Carl Nathan

Auto-generated profile, based on publicly available information

Carl Nathan

Department of Microbiology and Immunology, Weill Cornell Medicine, New York, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1997 in Annual Review of Immunology
Verified
Journal Article
Closed access
JMJohn MacMicking
John MacMicking
QXQiao-Wen Xie
Qiao-Wen Xie
CNCarl Nathan
Carl Nathan
▪ Abstract At the interface between the innate and adaptive immune systems lies the high-output isoform of nitric oxide synthase (NOS2 or iNOS). This remarkable molecular machine requires at least 17 binding reactions to assemble a functional dimer. Sustained catalysis results from the ability of NOS2 to attach calmodulin without dependence on elevated Ca2+. Expression of NOS2 in macrophages is controlled by cytokines and microbial products, primarily by transcriptional induction. NOS2 has been documented in macrophages from human, horse, cow, goat, sheep, rat, mouse, and chicken. Human NOS2 is most readily observed in monocytes or macrophages from patients with infectious or inflammatory diseases. Sustained production of NO endows macrophages with cytostatic or cytotoxic activity against viruses, bacteria, fungi, protozoa, helminths, and tumor cells. The antimicrobial and cytotoxic actions of NO are enhanced by other macrophage products such as acid, glutathione, cysteine, hydrogen peroxide, or superoxide. Although the high-output NO pathway probably evolved to protect the host from infection, suppressive effects on lymphocyte proliferation and damage to other normal host cells confer upon NOS2 the same protective/destructive duality inherent in every other major component of the immune response.

17 February 2006 in Nature Reviews Immunology
Verified
Journal Article
Closed access
CNCarl Nathan
Carl Nathan

1 December 2002 in Nature
Verified
Journal Article
Closed access
CNCarl Nathan
Carl Nathan

1 March 2010 in Cell
Verified
Journal Article
Closed access
CNCarl Nathan
Carl Nathan
ADAihao Ding
Aihao Ding

25 April 2013 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
CNCarl Nathan
Carl Nathan
ACAmy Cunningham-Bussel
Amy Cunningham-Bussel

1 August 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CNCarl Nathan
Carl Nathan
MSMichael U. Shiloh
Michael U. Shiloh
This review summarizes recent evidence from knock-out mice on the role of reactive oxygen intermediates and reactive nitrogen intermediates (RNI) in mammalian immunity. Reflections on redundancy in immunity help explain an apparent paradox: the phagocyte oxidase and inducible nitric oxide synthase are each nonredundant, and yet also mutually redundant, in host defense. In combination, the contribution of these two enzymes appears to be greater than previously appreciated. The remainder of this review focuses on a relatively new field, the basis of microbial resistance to RNI. Experimental tuberculosis provides an important example of an extended, dynamic balance between host and pathogen in which RNI play a major role. In diseases such as tuberculosis, a molecular understanding of host–pathogen interactions requires characterization of the defenses used by microbes against RNI, analogous to our understanding of defenses against reactive oxygen intermediates. Genetic and biochemical approaches have identified candidates for RNI-resistance genes inMycobacterium tuberculosisand other pathogens.